A comprehensive view of Horizon Therapeutics Plc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Amgen to lay off 350 workers at Horizon Therapeutics following their US$27.8B acquisition of the company; Amgen assures job placement for 80% of Horizon's workforce and supportive transition for those affected
Published:
October 24, 2023
by Chicago Tribune (IL)
|
Leerink upgrades Amgen to outperform, citing promising pipeline developments and recent acquisition of Horizon Therapeutics; substantial earnings boost also expected, as well as multiple market opportunities in obesity, inflammation and oncology sectors
Published:
October 18, 2023
by Zacks Investment Research
|
Amgen completes Horizon Therapeutics buyout for US$27.8B; Horizon's Tepezza, Krystexxa and Uplizna expected to enhance Amgen’s autoimmune portfolio
Published:
October 06, 2023
by FiercePharma
|
Amgen and Horizon Therapeutics reach a consent order agreement with the FTC, resolving an administrative lawsuit and clearing the way for Amgen’s acquisition of Horizon; the acquisition is expected to finalize early in Q4 2023
Published:
September 01, 2023
by Business Wire
|
FTC pauses legal proceedings to block Amgen's proposed takeover of Horizon Therapeutics, mulling potential settlement; possible resolution is under consideration until Sept. 18
Published:
August 28, 2023
by FiercePharma
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count